Follow The Filings

CGNX Cognex

Cognex earnings company data as of 4:00 PM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.53 — —
Rev $313.6M — —

Insider trades

Open-market buys and sales by CGNX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CGNX insider trades
  • None no insider bought on the open market
  • $21.1M sold by 6 insiders outside a trading plan
  • $13.7M sold by 4 insiders under 10b5-1 plans
  1. Matthew Moschner CEO
    Planned sale
    $1.6M 24,962 shares at $64.01 70% of stake
    Traded Aug 11 Filed Aug 12
  2. Darren Marc Long Vice President
    Sale
    $1.3M 20,252 shares at $66.34 84% of stake
    Traded May 27 Filed May 28
  3. Mark Fennell Chief Legal Officer &Secretary
    Sale
    $4.3M 64,873 shares at $67.05 100% of stake
    Traded May 11 Filed May 12
  4. Laura Ann Macdonald VP and PAO
    Sale
    $9.3M 139,722 shares at $66.43 96% of stake
    Traded May 11–12 Filed May 12
  5. Dianne M Parrotte Director
    Sale
    $2.4M 44,000 shares at $54.00 57% of stake
    Traded Mar 2 Filed Mar 3
  6. Angelos Papadimitriou Director
    Sale
    $231K 4,150 shares at $55.58 20% of stake
    Traded Feb 23 Filed Feb 24
  7. Joerg Kuechen Head of Corporate M&A
    Sale
    $3.5M 61,900 shares at $56.03 100% of stake
    Traded Feb 20 Filed Feb 24
  8. Carl Gerst EVP, Global Sales and Products
    Planned sale
    $802K 14,336 shares at $55.94 100% of stake
    Traded Feb 20–23 Filed Feb 24
  9. Robert Willett Director
    Planned sale
    $128K 2,148 shares at $59.50 100% of stake
    Traded Feb 13 Filed Feb 17
  10. Laura Ann Macdonald VP and PAO
    Planned sale
    $851K 14,881 shares at $57.16 87% of stake
    Traded Feb 12 Filed Feb 13
  11. Robert Willett Director
    Planned sale
    $10.3M 177,052 shares at $58.39 100% of stake
    Traded Feb 12 Filed Feb 13
  12. Robert Willett Director
    Planned sale
    $332K 6,704 shares at $49.51 100% of stake
    Traded Oct 21, 2025 Filed Oct 22, 2025

Also filed in the last 12 months, not counted as buying or selling: 67 option exercises and 21 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 7.01,8.01,9.01
10-Q
8-K 2.02,8.01,9.01
10-Q
8-K 2.02,8.01,9.01
8-K 5.02,5.07,9.01
SCHEDULE 13G —
SCHEDULE 13G —
SCHEDULE 13G/A —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf